Internal Medicine · Flushing, NY
NPI
1194737486
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4373 Union St, Suite C-B
Flushing, NY, 11355
Phone (718) 886-3877
Groups this clinician bills Medicare through
Medicare paid, 2024
$344K
5,627 services
Medicare patients, 2024
608
Average age 76
Drug cost, 2024
$3.0M
16,364 prescriptions
Company payments, 2025
$2,368
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vincent Y Wang was code 99490 (chronic, principal, and transitional care management), 1,393 times for 150 patients. In total Vincent Y Wang billed 5,627 services in 134 codes, and Medicare paid $344K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,393 | 150 | $52.84 | $74K |
| 99214 Office E&M - Established | Office | 637 | 234 | $105.60 | $67K |
| 99213 Office E&M - Established | Office | 625 | 291 | $72.31 | $45K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 265 | 104 | $42.07 | $11K |
| 36415 Venipuncture Blood Collection | Office | 259 | 129 | $8.62 | $2,232 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 245 | 101 | $13.98 | $3,425 |
| 99349 Home E&M - New and Established | Office | 199 | 37 | $104.96 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 193 | 48 | $67.48 | $13K |
| 99203 Office E&M - New | Office | 127 | 127 | $72.51 | $9,208 |
| G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 125 | 124 | $51.48 | $6,435 |
| G0008 Administration of influenza virus vaccine | Office | 124 | 122 | $36.36 | $4,508 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 114 | 114 | $143.82 | $16K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 106 | 106 | $21.11 | $2,237 |
| 99204 Office E&M - New | Office | 105 | 105 | $129.62 | $14K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 96 | 96 | $21.06 | $2,022 |
By year: 2022 $389K for 5,736 services; 2023 $364K for 5,354 services; 2024 $344K for 5,627 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 259 | 129 | $8.62 | $2,232 |
| 81003 Clinical Chemistry | 26 | 22 | $2.20 | $57.2 |
| 87880 Immunoassay | 11 | 11 | $16.20 | $178 |
Medicare prescription drug claims, 2024
In 2024, the drug Vincent Y Wang prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,096 prescriptions and refills. In total Vincent Y Wang wrote 16,364 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,096 | 2,191 | 277 | $7,330 |
| Vascepa Icosapent Ethyl | 948 | 1,226 | 179 | $420K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 495 | 1,045 | 130 | $7,109 |
| Losartan Potassium Generic | 484 | 1,031 | 143 | $3,005 |
| Rosuvastatin Calcium Generic | 409 | 867 | 116 | $2,961 |
| Metoprolol Succinate Generic | 383 | 769 | 100 | $3,704 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 383 | 665 | 118 | $1,256 |
| Diclofenac Epolamine Generic | 379 | 437 | 81 | $276K |
| Metformin Hcl Generic | 361 | 657 | 85 | $1,743 |
| Tamsulosin Hcl Generic | 334 | 599 | 81 | $2,305 |
| Alendronate Sodium Generic | 314 | 504 | 66 | $1,638 |
| Omeprazole Generic | 312 | 391 | 88 | $2,633 |
| Meloxicam Generic | 303 | 367 | 85 | $1,071 |
| Amlodipine Besylate Generic | 272 | 536 | 79 | $1,361 |
| Fluticasone Propionate Generic | 223 | 262 | 70 | $2,563 |
Brand drugs: 3,478 claims; generic drugs: 12,563 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vincent Y Wang $2,368 ($2,368 in general payments such as food, travel and fees) from 20 companies. The largest payer was Amgen Inc. with $1,057.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 16 | $1,057 |
| Abbvie Inc. ABBV | 10 | $211 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $195 |
| Gilead Sciences, Inc. GILD | 4 | $101 |
| GlaxoSmithKline, LLC. GSK | 5 | $98.31 |
| OPKO Pharmaceuticals, LLC | 4 | $82.73 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $78.56 |
| Novo Nordisk Inc NVO | 3 | $75.21 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $70.95 |
| Kowa Pharmaceuticals America, Inc. | 3 | $63.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.